This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Mukhopadhyay S, Wilcox BE, Myers JL, Bryant SC, Buckwalter SP, Wengenack NL, et al. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest. 2013;144:813–24.
Thiessen R, Seely JM, Matzinger FR, Agarwal P, Burns KL, Dennie CJ, et al. Necrotizing granuloma of the lung: imaging characteristics and imaging-guided diagnosis. AJR Am J Roentgenol. 2007;189:1397–401.
Aubry MC. Necrotizing granulomatous inflammation: what does it mean if your special stains are negative? Mod Pathol. 2012;25(Suppl 1):S31–8.
Hunninghake GW, Garrett KC, Richerson HB, Fantone JC, Ward PA, Rennard SI, et al. Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis. 1984;130:476–96.
Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y, et al. Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [(18)F]FDG PET/CT findings. Eur J Nucl Med Mol Imaging. 2021;48:73–86.
Hao B, Wu X, Pang Y, Sun L, Wu H, Huang W, et al. [(18)F]FDG and ([68)Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions. Eur J Nucl Med Mol Imaging. 2021;48:651–2.
The study was partially funded by the ERF-SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty).
Conflict of interest
Jeremie Calais is the recipient of grants from the ERF-SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty), the Philippe Foundation Inc. (NY, USA), and the ARC Foundation (France) (International Mobility Award SAE20160604150). Jeremie Calais is a consultant for Blue Earth Diagnostics, Curium Pharma, GE Healthcare, Janssen Pharmaceuticals, Progenics Radiopharmaceuticals, Radiomedix, and Telix Pharmaceuticals, outside of the submitted work. All other co-authors have no conflict of interest.
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Written and oral informed consent was provided by the patient involved in this study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Infection and inflammation
About this article
Cite this article
Hotta, M., Benz, M.R., Allen-Auerbach, M.S. et al. High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma. Eur J Nucl Med Mol Imaging (2021). https://doi.org/10.1007/s00259-021-05510-0